Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition.
Ćurčić V, Olszewski M, Maciejewska N, Višnjevac A, Srdić-Rajić T, Dobričić V, García-Sosa AT, Kokanov SB, Araškov JB, Silvestri R, Schüle R, Jung M, Nikolić M, Filipović NR.
Ćurčić V, et al. Among authors: olszewski m.
Arch Pharm (Weinheim). 2024 Feb;357(2):e2300426. doi: 10.1002/ardp.202300426. Epub 2023 Nov 22.
Arch Pharm (Weinheim). 2024.
PMID: 37991233